BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14663052)

  • 1. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP.
    Jann S; Bramerio MA; Beretta S; Koch S; Defanti CA; Toyka KV; Sommer C
    Neurology; 2003 Dec; 61(11):1607-10. PubMed ID: 14663052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
    Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
    Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
    Lotan I; Hellman MA; Steiner I
    Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of CIDP in patients with diabetes or CMT1.
    Latov N
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
    Leppert D; Hughes P; Huber S; Erne B; Grygar C; Said G; Miller KM; Steck AJ; Probst A; Fuhr P
    Neurology; 1999 Jul; 53(1):62-70. PubMed ID: 10408538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria.
    Haq RU; Fries TJ; Pendlebury WW; Kenny MJ; Badger GJ; Tandan R
    Arch Neurol; 2000 Dec; 57(12):1745-50. PubMed ID: 11115240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy.
    Fleischer M; Lee I; Erdlenbruch F; Hinrichs L; Petropoulos IN; Malik RA; Hartung HP; Kieseier BC; Kleinschnitz C; Stettner M
    J Neuroinflammation; 2021 Apr; 18(1):89. PubMed ID: 33832507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
    Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
    J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demyelinating neuropathy in diabetes mellitus.
    Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
    Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
    Jann S; Bramerio MA; Facchetti D; Sterzi R
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research criteria for defining patients with CIDP.
    Sander HW; Latov N
    Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; Van den Berg LH; De Boer L; Van Son MJ; Veldman H; Franssen H; Logtenberg T; Wokke JH
    Neurology; 1999 Sep; 53(4):837-45. PubMed ID: 10489051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
    Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].
    Sun QL; Sun AP; Fu Y; Fan DS
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):749-752. PubMed ID: 30293336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves.
    Ohkoshi N; Harada K; Nagata H; Yato M; Shoji S
    Eur Neurol; 2001; 45(4):241-8. PubMed ID: 11385262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
    Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
    PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
    Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
    Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
    Kalita J; Misra UK; Yadav RK
    Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
    Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW
    J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy.
    Molenaar DS; Vermeulen M; de Haan R
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):84-9. PubMed ID: 9436733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.